ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,416.45
-0.09%
Dow Jones
39,864.77
0.15%
Gold vs US Dollar
2,424.315
-0.09%
Brent Oil
82.775
-0.90%
Bitcoin
69,229.09
-3.11%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Biodesix Inc (BDSX)

  7. Biodesix Inc (BDSX) News

Biodesix (BDSX)

Biodesix Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BDSX
DateTimeSourceHeadlineSymbolCompany
21/05/202411:00Business WireBiodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual MeetingNASDAQ:BDSXBiodesix Inc
10/05/202422:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
10/05/202422:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
10/05/202422:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
10/05/202422:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
10/05/202422:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
09/05/202421:07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BDSXBiodesix Inc
09/05/202421:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BDSXBiodesix Inc
09/05/202421:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BDSXBiodesix Inc
09/05/202421:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BDSXBiodesix Inc
08/05/202421:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BDSXBiodesix Inc
08/05/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDSXBiodesix Inc
08/05/202421:01Business WireBiodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule ManagementNASDAQ:BDSXBiodesix Inc
07/05/202411:00Business WireBiodesix to Participate in the 2024 RBCCM Global Healthcare ConferenceNASDAQ:BDSXBiodesix Inc
24/04/202411:00Business WireBiodesix to Report First Quarter 2024 Financial Results on May 8, 2024NASDAQ:BDSXBiodesix Inc
09/04/202422:00Business WireBiodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual MeetingNASDAQ:BDSXBiodesix Inc
05/04/202412:17Business WireBiodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private PlacementNASDAQ:BDSXBiodesix Inc
25/03/202410:00Business WireBiodesix Announces New Master Collaborative Research Agreement with Leading US Cancer CenterNASDAQ:BDSXBiodesix Inc
01/03/202411:11Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BDSXBiodesix Inc
01/03/202411:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDSXBiodesix Inc
01/03/202411:00Business WireBiodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business HighlightsNASDAQ:BDSXBiodesix Inc
29/02/202423:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
29/02/202423:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
29/02/202423:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
29/02/202423:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
29/02/202423:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
26/02/202411:00Business WireBiodesix to Participate in the TD Cowen 44th Annual Health Care ConferenceNASDAQ:BDSXBiodesix Inc
16/02/202411:00Business WireBiodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024NASDAQ:BDSXBiodesix Inc
13/02/202402:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
13/02/202402:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
 Showing the most relevant articles for your search:NASDAQ:BDSX

Your Recent History

LSE
TERN
Tern
LSE
BP.
Bp
LSE
POS
Plexus
LSE
SCLP
Scancell
LSE
VAST
Vast Resources
LSE
VAL
Valirx
LSE
YU.
Yu
LSE
GKP
Gulf Keystone Petroleum
LSE
PHE
Powerhouse Energy
LSE
THG
Thg
LSE
TEK
Tekcapital
LSE
MIN
Minoan
LSE
SOLG
Solgold
LSE
POLX
Polarean Imaging
LSE
SYME
Supply@me Capital
LSE
AAZ
Anglo Asian Mining
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved